Knockdown of EIF4G1 in NSCLC induces CXCL8 secretion

Ziyang He1, Fangyi Li2, Xinyi Zhang2

  • 1Research Center for Translational Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.

Frontiers in Pharmacology
|February 26, 2024
PubMed

Insights

Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) influences inflammation in non-small cell lung cancer (NSCLC). Knockdown of EIF4G1 upregulates inflammatory factors like CXCL8, impacting immune cell chemotaxis in NSCLC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Non-small cell lung cancer (NSCLC) lacks effective early detection and therapeutic targets.
  • Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) is crucial for protein synthesis but its role in NSCLC is undefined.

Purpose of the Study:

  • To investigate the function of EIF4G1 in NSCLC.
  • To explore the relationship between EIF4G1, inflammation, and immune cell activity in NSCLC.

Main Methods:

  • Transcriptome sequencing of H1299 NSCLC cells with EIF4G1 knockdown.
  • Analysis of inflammatory cytokine expression in NSCLC tumor tissues.
  • Investigation of EIF4G1's regulation of TNFRSF10A, MAPK, and NFκB pathways.
  • Assessment of immune cell chemotaxis.

Main Results:

  • EIF4G1 knockdown upregulated inflammation-related factors and CXCL8 in NSCLC cells.
  • CXCL8 was significantly overexpressed in NSCLC tumor tissues.
  • EIF4G1 regulates TNFRSF10A, activating MAPK and NFκB pathways, inducing CXCL8 secretion.
  • EIF4G1 knockdown enhanced H1299 cell and macrophage chemotaxis.

Conclusions:

  • EIF4G1 plays a significant role in the inflammatory response within NSCLC.
  • EIF4G1 influences immune cell recruitment via CXCL8-mediated chemotaxis.
  • EIF4G1 may represent a potential therapeutic target for NSCLC treatment.